Moreover, studies in vivo and in vitro have reported that EGFR overexpression was involved in corticotroph tumor formation, cell proliferation, Pomc expression, and ACTH secretion via mitogen-activated protein kinase (MAPK) activation, and these factors are inhibited by EGFR inhibitors [9,11,12]. Here, POMC is linked to neoplasm.